PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nuveen Asset Management, LLC | 13,804 | $62,118 | 0.00% |
HighMark Wealth Management LLC | 50 | $225 | 0.00% |
Tower Research Capital LLC (TRC) | 2,090 | $9,405 | 0.00% |
Cutler Group LLC / CA | 130 | $0 | 0.00% |
JPMORGAN CHASE & CO | 9,339 | $42,026 | 0.00% |
BARCLAYS PLC | 6,052 | $27 | 0.00% |
ROYAL BANK OF CANADA | 5,279 | $24,000 | 0.00% |
D. E. Shaw & Co., Inc. | 55,838 | $251,271 | 0.00% |
VANGUARD GROUP INC | 952,938 | $4,288,221 | 0.00% |
Mirae Asset Global Investments Co., Ltd. | 10,087 | $45,392 | 0.00% |
Ameritas Investment Partners, Inc. | 819 | $3,686 | 0.00% |
TD ASSET MANAGEMENT INC | 80,326 | $361,467 | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 3,297 | $14,837 | 0.00% |
UBS Group AG | 6,892 | $31,015 | 0.00% |
RHUMBLINE ADVISERS | 29,819 | $134,185 | 0.00% |
Squarepoint Ops LLC | 19,127 | $86,072 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 39,290 | $176,805 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 14,131 | $63,604 | 0.00% |
External links
This page lists PRELUDE THERAPEUTICS INC's shareholders in Q2 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.